Singapore-based Heal Venture Lab Partners with RiteMED

April 2024

RiteMED and Heal Venture Lab are collaborating to strengthen Universal Health Care (UHC) in the Philippines through the use of modern technology. Their focus is on enhancing access to quality healthcare in line with the government’s UHC Law. RiteMED, as one of the country’s leading unbranded generic company, is partnering with Heal Venture Lab (HVL), a Singaporean venture specializing in healthcare technology with social impact goals.

The strength of this partnership lies in RiteMED’s industry leadership and HVL’s expertise in boosting health technology across key areas such as market entry, product prototyping, distribution and investor networks. This collaboration has the potential to significantly impact the accessibility of affordable and high-quality healthcare for Filipino communities. By engaging with young entrepreneurs and STEM students, they aim to foster innovative solutions for local healthcare challenges.

Leveraging HVL’s network and expertise alongside RiteMED’s industry experience, the collaboration may lead to advancements in diagnostics, treatments and overall healthcare accessibility. Additionally, they plan to organize events that connect young innovators with industry partners and government bodies. This collaboration reflects a shared commitment to improve healthcare affordability and quality, supporting the effective implementation of UHC in the Philippines.

(Source: BusinessMirror)

Our Services

Orissa International provides consulting services to companies that want to develop a market entry strategy for Southeast Asia or implement their business expansion into the region. We have very strong domain knowledge of markets and industry sectors, and a business network of over 16,000 distributors, resellers, and system integrators, built through advising and guiding more than 5,000 companies with their market expansion into Singapore, Malaysia, Indonesia, Thailand, Vietnam and the Philippines over the last 25 years.